Affymetrix and Asuragen Sign Agreement to Develop IVT Reagent Kits for Molecular Diagnostic Applications

Affymetrix Inc. (NASDAQ:AFFX) and Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to license, develop and manufacture in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications.

Source: Affymetrix